Sulfasalazine salicylazosulfapyridine (SASP), consisting of 5-aminosalicylic acid bound to sulfapyridine by a diazo bond, is an eŠective drug in the treatment of in‰ammatory bowel diseases (IBD). Howerer, its mechanism of action remains a matter of debate. The objective of our work was to investigate SASP's eŠect on NF-kB signal transduction pathway in transcriptional regulation level. Repeated colitis was induced by administration of 4 cycles of 4％ dextran sulfate sodium (DSS); The severity of colitis was assessed on the basis of clinical signs, colon length, and histology scores. Moreover, sIgA and haptoglobin (HP) were analyzed by enzyme linked immunosorbent assay, and ICAM-1 gene expression was analyzed by quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR) using SYBA green I. NF-kB signal transduction proteins and transcriptional factor p65 interaction with promoter of ICAM-1 were assessed by western blotting and chromatin immunoprecipitation assay. SASP administration signiˆcant-ly attenuated the colitis signs and caused substantial reductions of HP expression, and maintained the level of cecum sIgA. SASP inhibited ICAM-1 gene expression and had no eŠect on MIF gene expression. Also, SASP was able to reduce p-IkBa protein expression; however, no change in the activation of IKKa, IKKb, p65, and IKBa was noted. SASP inhibited p65 recruitment to the gene ICAM-1 promoter. In conclusion, inhibition of NF-kB pathway signal proteins and blockade of p65 binding to gene ICAM-1 promoter might explain the eŠect and mechanisms of SASP at alleviating DSS-induced colitis in mice.
INTRODUCTION
Sulfasalazine salicylazosulfapyridine (SASP), the prodrug of 5-ASA, is an eŠective treatment against in‰ammatory bowel diseases (IBD) by blocking the production of prostaglandins and leukotrienes, inhibiting bacterial peptide induced neutrophil chemotaxis and adenosine-induced secretion, scavenging reactive oxygen metabolites and so on. 1 4) Although this drug has been used for decades, its mechanism of action remains a matter of debate.
IBD comprises a number of the chronic immunoin‰ammatory disorders of the gastrointestinal tract in which this immunological balance is severely impaired. 5 7) The nuclear transcription factor kappaB (NF-kB) has been identiˆed as one of the key regulators in this immunological setting. The amount of activated NF-kB correlated signiˆcantly with the severity of intestinal in‰ammation. 8, 9) Accumulating evidence has indicated that migration of leucocytes to the site of in‰ammation is related to ICAM-1, and enhanced colonic mucosal endothelial cell ICAM-1 expression is an early event in the in‰ammatory cascade of acute colitis. 10, 11) Proin‰ammatory factor ICAM-1 expression is regulated via NF-kB signal transduction activation. So far, there is no report about its eŠect on transcriptional regulation of the interaction of transcription factor p65 and promoter of gene ICAM-1 in ulcerative colitis.
The objectives of this study were therefore to examine the eŠects and potential mechanisms of SASP on chronic colitis. To address these objectives, we employed repeated colitis model in C57bl/6 mice induced by administration of 4 cycles of 4％ dextran sulfate sodium (DSS), which produces in‰ammation limited to the colonic mucosa that is closely related to human ulcerative colitis. 12, 13) 
METHODS

Materials
SASP was purchased from Shanghai 
Animal Care
Female C57BL/6 mice, 6 weeks of age, obtained from the animal centre of Southern Medical University were housed 5 6/cage, and kept at the animal house facilities with room temperature of 20±2°C, 50％ humidity and 12: 12-h light-dark cycles, fed a standard pellet diet, and administered tap water ad libitum. The Animal Research Board Committee of Southern Medical University approved the studies. Mice were acclimatized for 2 weeks before the study. Body weights, drink water and food consumption were measured every week for the duration of the experiment.
After a 7-day acclimation period, a total of 36 mice were randomly distributed into three groups. Group 1 (n＝11) was administered water as normal control. Groups 2 and 3 received four cycles of DSS administration (each cycle 4％ DSS dissolved in distilled water for 7 days then distilled water alone for 7 days). This schedule was used to simulate the cycle of acute ‰are-ups alternating with periods of disease inactivity observed in human ulcerative colitis patients. 13, 14) Group 2 (n＝15) was administered distilled water by oral gavage 10 ml/kg once daily for the whole experimental period. Group 3 (n＝10) was administered SASP 4 g/10 ml/kg solution by oral gavage once daily for the whole experimental period. Mice were weighed every week for the determination of percent weight change. This was calculated as: ％ weight change＝(weight at week X-week 0/weight at week 0)×100. Animals were monitored clinically for occult and rectal bleeding, diarrhea, and general signs daily. Occult blood in the feces was evaluated by the orthotolidine methods. Occult blood scores and stool consistency scores were determined according to a standard scoring system, as previously described by Shimon et al. 14) Histological Scoring The mice were killed by dislocation after 56 days' experiments. The colon was resected between the ileocecal junction and the proximal rectum, close to its passage under the pelvisternum. The colon was placed onto a non-absorbent surface and measured by a ruler, taking care not to stretch the tissue. Colon length was measured as an indication of colonic in‰ammation. Some colonic tissues were stored at -80°C for PCR and western blotting.
The colonic tissues wereˆxed with 10％ neutral buŠered formalin. Serial tissue sections (3 mm) were made and mounted on glass slides and routinely stained with hematoxylin and eosin and Alcian blue for histopathological analysis. Sections were coded with an accession number and reviewed by a pathologist without access to the code. Each section was scored for lesions based on severity, ulceration, hyperplasia and crypts alteration according to the method of Melgar et al. 13) Scanning Electron Microscopy Specimens from all groups were processed using a standard technique for scanning electron microscopy (SEM). Fragments 4 mm from colonic tissues wereˆxed with 2.5 glutaraldehyde in 0.1 M Sorensen's phosphate buŠer (pH7.4) at room temperature for 24 h. Samples were then postˆxed in a phosphate-buŠered 2％ osmium tetroxide solution at 4°C for 1 h. The samples were glued onto stubs, coated with gold in a SCD040 Balzer Sputterer and observed by a Philips 505 SEM at 10  30 kV.
Immunohistochemistry Immunohistochemical staining was performed by avidin-biotin peroxidase complex method as described previously. 16) In brief, endogenous peroxidase activity was quenched in para‹n-embedded tissue sections with 1％ H 2 O 2 . An-tigen was retrieved by pretreatment with citrate buŠer in high pressure heating then the slides were incubated with primary antibody ICAM-1 (1: 1000 dilution) followed by the appropriate PV-6001 IgG secondary antibody for 45 min each. Diaminobenzidine was used as chromagen. Slides were washed thoroughly between incubations with PBS. Negative controls were established by replacing the primary antibody with PBS and normal serum. Positive staining was indicated by the presence of brown-colored precipitate.
Production of Secretory Immunoglobulin A Cecum content was collected rapidly, suspended in twofold saline (V/W), and centrifuged at 5000prm and 4°C for 5 min. Content of cecum sIgA was determined by mouse secretory immunoglobulin A (sIgA) double antibody sandwich ELISA Kit according to the manufacturer's protocol.
Production of HP
Blood was collected into heparin tube from mice via removing eyeball. Care was taken to minimize hemolysis, and sample were stored at -20°C. The HP concentrations in the plasma were determined similarly as sIgA.
RNA isolation and qRT-PCR Using SYBR Green I Fluorescent Dye
Specimens were immediately stored in RNAlater solution for 24 h, then stored at -20°C. The RNAlater-preserved colon tissues were homogenized and extracted using trizol reagent according to the manufacturer's instructions. Extracted RNA was dissolved in 20 ml water. Two mg of total RNA from each sample was converted into cDNA. cDNA synthesis was performed as kit instruction. Relative gene expression quantitation for ICAM-1, Macrophage-migration inhibitory factor (MIF) with GAPDH as internal reference gene, was carried out using MX3005 real time PCR ampliˆcation detection system in triplicate, based on the SYBR-Green method. Primer sequences were as follows: ICAM-1, sense 5′ -CAACTGGAAGCTGTTTGAGCTGAG-3′ andreverse 5′ -AGGGTGAGGTCCTTGCCTACTTG-3′ ; MIF, sense 5′ -CTGCACAGCATCGGCAAGA-3′ and reverse 5′ -TTGGCAGCGTTCATGTCGTAA-3′ ; GAPDH, sense 5′ -AAATGGTGAAGGTCGGTGTG-3′ and reverse 5′ TGAAGGGGTCGTTGATGG-3′ . The PCR reaction mixture consisted of 0.1 mmol/l of each primer, 1×SYBR Premix EX Taq (Perfect Real Time) premix reagent, and 50 ng cDNA to aˆnal volume of 20 ml. Cycling conditions were 95°C for 10 min, followed by 40 cycles at premature 95°C for 5 s, annealing temperature was 59°C, 30 s. PCR speciˆcity was conˆrmed by dissociation curve analysis and gel electrophoresis. The relative induction of gene mRNA expression, comparative Delta-delta Ct was calculated using the following equation: DDCt＝(Ct, target-Ct, GAPDH)treatment -(Ct, target-Ct, GAPDH)nontreatment, andˆnal data were derived from 2 -averageDDCt . GAPDH was used as internal control.
Western Blot Analysis Colonic tissue was dounced on ice and lysed by adding protease inhibitor cocktail and PhosSTOP working solutions. Protein 100 mg was subjected to electrophoresis on 10％ SDSpolyacrylamide gels. p65 rabbit mAb, IkBa mouse mAb and phospho-IkBa (Ser32) rabbit mAb were used to detect immunoreactive NF-kB p65 (1: 2000), IkBa (1: 2000) and pho-IkBa (1: 2000), respectively. The membranes were visualized with ECL Plus reagent and viewed by Kodak image station 4000 MM digital imaging system. The reactions were carried out in triplicate.
Chromatin Immunoprecipitation Analysis Chromatin immunoprecipitation (Chip) analysis was performed according to Chip kit instruction. Brie‰y, colon tissues were crushed carefully to obtain pieces as small as possible with liquid nitrogen, cellular proteins and DNA were crosslinked by adding formaldehyde to PBS to aˆnal concentration of 0.1％. Tissues were completely resuspended with 10 ml GlycineStop-Fix solution and lysed with SDS buŠer. Lysates were sonicated utilizing an American Ultrasonic Processor VG 130 and precleared with Chip blocked protein G agarose. Lysates were then incubated at 4°C with anti-p65 antibody, anti-RNA polymerase II (Upstate Biotechnologies), and IgG antibodies overnight. Complexes were precipitated and serially washed three times each with low salt, high salt, LiCl wash and TE buŠer. Washed complexes were eluted with freshly prepared elution buŠer, and reverse crosslinks of protein/DNA complexes to free DNA. Then DNA was puriˆed by PCR puriˆcation column. Puriˆed DNA was then ampliˆed across the ICAM-1 promoter region utilizing the primers sense 5′ -GGAC-CAGACATCTTCCTTCCTTT-3′ and reverse 5′ -TCACTTCCCTTCTCCCACTCAC-3′ . The amplied product was detected by the presence of a SYBR green I ‰uorescent signal and calculated as described in section on qRT-PCR.
Statistical Analysis Data were analyzed by SPSS 13.0 statistical software and are expressed as the 
RESULTS
Mice treated with DSS 40 mg/g body weight/day are shown in Fig 1a. No mice death during experiment. As shown in Fig. 1c , the percent weight change of DSS-induced colitis had obviously decreased and colitis gave rise to visible bloody stools, perianal bleeding, and weak strength. In‰ammatory changes of the intestinal tract were associated with signiˆcant ( p＜0.01) augmentation of weight/length of the mice colon ( Table 1 ). The colon for DSS-treated mice appeared edematous, and the intestine wall was thick and in‰amed withˆbrotic thickening of tissue while soft and amorphous as shown in Fig. 2 .
Whereas SASP treatment in DSS-mice signiˆcantly reduced loss of body weight, stool consistency scores, and fecal occult blood score as shown in Fig. 1 . No signiˆcant increase in the weight/length of the mice colon and spleen coe‹cient was found in SASP group compared with normal group ( p＞0.05).
On histological examination of colon from normal group mice, the histological features of the colon were typical of a normal structure. In DSS-treated mice, the in‰ammation extended through the mucosa, muscularis mucosae and submucosa. Extensive granulation tissue with the presence ofˆbroblasts and lymphocytes, leukocytes, and diŠuse in‰ammatory inˆltrates was apparent. In some sections of ulcerated areas necrotic tissue adjacent to surface cells could be observed. The mucosa adjacent to ulcers showed grossly elongated crypts. Furthermore, severe and extensive denudation of the surface epithelium (erosions) and mucodepletion of glands appeared. After administration of SASP, the colonic histopathology was dramatically reduced, there was attenuation of morphological signs of cell damage, the colonic mucosa showed ulcers in the process of healing, evolution to a more chronic in‰ammatory inˆltrate, with mononuclear predominance and initiation of a repair process. Goblet cells with Alcian blue-positive cells (acid glucoproteins such as sialomucins) were clearly observed in regions with reepithelization of the mucosal layer, whereas in contrast, remarkable mucin depletion was observed in ulcerative areas (Fig. 3) .
ICAM-1-immunohistochemistry showed strong immunoreactivity in the mucosa, muscularis mucosae and submucosa in DSS group, whereas in contrast, SASP reduced positive cell numbers and stain intensity. Quantitation of immunostain-positive cell numbers percentage showed that there was signiˆcant diŠerence between normal and DSS group (8.84± 0.54 vs. 95.21±1.54). Stain intensity was also greater in DSS groups compared with SASP group, as shown in Fig. 4 .
SEM observations of the colonic mucosa in normal group mice showed well-deˆned concave grooves, and regular-shaped crypt openings containing mucin-like material. Mice that underwent 4 cycles of DSS administration showed widened grooves, dilatations of glandular crypts losing their regular shape by assumingˆssure-like aspects, petal-like swelling and depletion of goblet cells, leaving an irregular crater-like area. A widely damaged surface epithelium with a dishomogeneous distribution of microvilli characterized the in‰amed mucosa (Fig. 5) . Whereas SASP group showed integrity of mucosa architecture, witĥ lamentous microvilli, surface loosening and no swelling.
As show in Fig. 6 , an important increase in plasma HP and decrease in cecum sIgA characterized the colitis caused by DSS, which was consistent with the histologicalˆndings. Moreover, after treatment with SASP, the data clearly indicate a signiˆcant reverse alteration.
We then analyzed levels of gene ICAM-1 expression measured by qRT-PCR. The ampliˆcation kinetics of the gene ICAM-1, MIF and GAPDH assays were approximately equal and gel electrophoresis of PCR products was single band, therefore we used comparative Ct (DDCt) method for determination of ICAM-1 gene expression. As shown in Fig. 7 , the ICAM-1 gene expression fold change of DSS treated DSS induced IkBa phosphorylation (0.63 vs. 0.30). Administration of SASP was able to diminish IkBa phosphorylation. However, no change in the activation of IKKa, IKKb, p65 and IkBa was observed as shown in Fig. 8 .
DSS treatment activated NF-kB transcriptional factor p65 binding at the ICAM-1 gene promoter, increasing to 6.47 vs. normal group 2.08 (Fig. 9) . Conversely SASP reduced the NF-kB p65 binding at the ICAM-1 gene promoter. The SYBA green I PCR product of ICAM-1 promoter DNA fragmentation was validated by DNA sequencing.
DISCUSSION
Clinically recommended drug therapies for IBD include 5-aminosalicylic acid, corticosteroids, immunosuppressants, immunoregulatory agents, antibiotics and probiotics, and anti-TNF-a therapy. The antiin‰ammation mechanism of corticosteroids for IBD is related to inhibition of PGs and release of proin‰ammatory cytokines, such as IL-1 and TNF-a. However in some patients, the side eŠects and steroidresistant ulcerative colitis correlate with the dose and duration of corticosteroids treatment. 17) Indeed, there is no clinically eŠective drug for IBD. SASP waŝ rst developed in 1942, this agent has been the parent aminosalicylate in use for ＞60 years and consists of 5-aminosalyclic acid linked by an azo bond to sulfapyridine. It combines an antibacterial agent (sulfapyridine) with an anti-in‰ammatory component (5-ASA). 1) The sulfonamide moiety acts as a carrier to deliver the active component 5-ASA to the colon where it is released by bacterial action. SASP has proven e‹cacy, and has a well-deˆned dose-response for induction of remission and maintenance of disease control in ulcerative colitis. The main mechanism includes inhibition of cyclooxygenase and lipoxygenase pathways to reduce production of PGs and leuokotrienes, respectively. 3) The principleˆndings of our study indicate that SASP could markedly improve symptom appearance after starting DSS administration. Average body weights in SASP group at the end of the experiment increased whereas DSS group showed obvious weight loss. There were no diŠerences in average food and water consumption among all groups. As we know, the protective eŠect of mucus as an active barrier may be attributed largely to its viscous and gel-forming properties that are derived from mucin glycoprotein constituents. Alcian blue-positive cells seem to be associated with regenerative processes of the colonic mucosa, whereas by contrast, reduction of the cells is related to decreased resistance of the mucosa and paralleled by alterations in the normal pattern of maturation of mucin in goblet cells. sIgA is also a component of mucin, our experiment showed that SASP protected the crypt gland, mucous architecture, and maintained the cecum sIgA level. All these observations may have signiˆcance on the beneˆcial eŠect of SASP on colitis.
Compelling evidence suggested that increased luminal bacterial adherence is an important factor driving host colon mucosal immune system responses and contributes to an ampliˆcation loop of increased colonization and in‰ammation, and activates TLRs signaling pathways that culminates in activation of NF-kB transcription factors. Colon epithelia and local plasma cells produce preferentially secretory dimers and larger polymers of IgA and perform immune exclusion inˆrst-line defense, thereby counteracting microbial colonization and mucosal penetration of soluble antigens. 18, 19) Plasma HP, one of the acute-phase proteins acts as the biological activity marker of in‰ammatory bowel disease, although none of the pertinent laboratory surrogate markers of disease activity in IBD is speciˆc or sensitive enough to replace basic clinical observation such as the number of daily bowel movements, general well-being, and other parameters in parallel. SASP showed protective eŠect such as increase of cecum sIgA and decrease of plasma HP.
Accumulating evidence indicates that migration of leucocytes to the site of in‰ammation is related to ICAM-1, and enhanced colonic mucosal endothelial cell ICAM-1 expression is an early event in the in‰am-matory cascade of acute colitis. 10) Our results showed that ICAM-1 gene expression was corrected with the development of colonic in‰ammation and moreover SASP administration was able to diminish ICAM-1 Mice with DSS colitis that had received distilled water demonstrated intense staining for ICAM-1 in epithelial cells and polynuclear inˆltrates in the mucosa, muscularis mucosae, submucosa and the lamina propria. c, f: Section of colon from mice with DSS colitis that had received SASP after induction of colitis. Immunohistochemistry revealed that epithelial cell staining for ICAM-1 was considerably less intense than in mice that had received distilled water after induction of DSS colitis. Original magniˆcation: a, b and c, ×200. d, e and f, ×400. gene expression.
MIF is an ubiquitously expressed cytokine with a variety of mitogenic and pro-in‰ammatory functions. 20 22) Plasma concentrations of MIF in patients with active Crohn's disease were sixfold higher than in healthy individuals, and the development of chronic colitis is dependent on MIF. 23) Our data indicate that SASP had no apparent eŠect on MIF gene expression in DSS treated mice. Immune and in‰amma-tory cytokines often activate NF-kB signal pathway, and induce p65 nucleus translocation for synthesis of numerous proin‰ammatory cytokines and adhesion proteins such as ICAM-1. 24, 25) Our results show that SASP administration induced IkBa phosphorylation.
At present, there are no data concerning the eŠect of SASP on transcriptional regulation on the interaction of transcription factor p65 and promoter of gene ICAM-1 in ulcerative colitis mice. Our research indicates that SASP inhibited the high level of TF p65 at the site of ICAM-1 promoter.
In summary, the data presented in the current study show that SASP reduces development of chronic experimental colitis and alleviates in‰ammatory response. We suggest that inhibition of NF-kB signal pathway is the main target of SASP for anti-in‰am-matory treatment of IBD.
